Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102030798B reveals a novel triflate salt purification method for Abiraterone Acetate. Achieves >97% purity, eliminates chromatography, and ensures scalable supply.
Patent CN110642790B details a novel Rosuvastatin Calcium route using Evans auxiliaries. Achieve high purity solid intermediates and cost reduction in API manufacturing.
Novel VX-960 synthesis avoids low-yield oxidation. Enhances supply chain reliability and cost efficiency for hepatitis C treatment manufacturing.
Novel cyanoacetic acid route for 2-chloro-5-cyanopyrimidine. Eliminates heavy metals and phosgene. Cost-effective industrial scale-up for API manufacturing.
Discover the novel preparation of 7-hydroxy-[1,2,4]triazolo[1,5-a]pyridine via patent CN114671867A. Achieve high purity and scalable manufacturing for HER2 inhibitors.
Novel 8-step synthesis of 5-fluoro-3-methylisobenzofuranone from phthalimide. High yield, low cost route for Laratinib intermediate suitable for commercial scale-up.
Patent CN109503568A details a high-yield Dasatinib synthesis using ionic liquids and copper catalysis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1222537C reveals a novel Fmoc-strategy for Eptifibatide synthesis, eliminating toxic HF and reducing cycle time. Ideal for reliable peptide intermediate sourcing.
Novel phase-transfer catalysis method enhances Vildagliptin purity and yield. Offers significant cost reduction in API manufacturing and supply chain reliability for global partners.
Patent CN110950872A details a high-yield Boc-protection strategy for Avapritinib, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Advanced 4-step synthesis of Trilaciclib intermediate via mild conditions. Reduces purification costs and enhances supply chain reliability for CDK4/6 inhibitors.
Novel route for Cabazitaxel (XRP6258) using DMSO/Acetic Anhydride. High yield, scalable process for pharmaceutical intermediates reducing production costs.
Patent CN115636776A details a novel Alprostadil synthesis using PGF2α waste. This green method offers significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Patent CN101863861A reveals efficient beta-lactam route for Larotaxel, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN107935997A reveals a cost-effective Osimertinib route avoiding expensive chloropyrimidine. Enhance supply chain reliability with scalable manufacturing.
Patent CN114181132A reveals a novel high-purity synthesis route for nintedanib intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN110777391B reveals a green electroreduction method for gefitinib intermediates, offering high purity, reduced costs, and scalable manufacturing for global pharmaceutical supply chains.
Patent CN111138492B details a high-yield Brigatinib synthesis avoiding column chromatography. This report analyzes cost reduction and supply chain reliability for API manufacturing.
Patent CN102010455B reveals a novel Decitabine synthesis avoiding isomer separation. High purity >99.85% via Barton-McCombie deoxygenation for cost-effective manufacturing.
Discover the optimized synthesis of quinoline angiogenesis inhibitors via CN102356063A. Enhance purity and safety in pharmaceutical intermediate manufacturing.